Gujarat Kidney Super Speciality Ltd vs Invicta Diagnostic Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Gujarat Kidney & Super Speciality Ltd is ₹ 176.95 as of 23 Oct 15:30 . The P/E Ratio of Gujarat Kidney & Super Speciality Ltd changed from 51.4 on March 2026 to 0 on March 2023 . This represents a CAGR of -100.00% over 2 yearsThe P/E Ratio of Invicta Diagnostic Ltd changed from 16.1 on March 2026 to 0 on March 2023 . This represents a CAGR of -100.00% over 2 years The Market Cap of Gujarat Kidney & Super Speciality Ltd changed from ₹ 798.29 crore on March 2026 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 2 yearsThe Market Cap of Invicta Diagnostic Ltd changed from ₹ 79.2 crore on March 2026 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 2 years The revenue of Gujarat Kidney & Super Speciality Ltd for the Jun '26 is ₹ 34.98 crore as compare to the Mar '26 revenue of ₹ 31.29 crore. This represent the growth of 11.79% The revenue of Invicta Diagnostic Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Gujarat Kidney & Super Speciality Ltd for the Jun '26 is ₹ 9.07 crore as compare to the Mar '26 ebitda of ₹ 7.01 crore. This represent the growth of 29.39% The ebitda of Invicta Diagnostic Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Gujarat Kidney & Super Speciality Ltd changed from ₹ 2.96 crore to ₹ 5.32 crore over 8 quarters. This represents a CAGR of 34.06% The net profit of Invicta Diagnostic Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Gujarat Kidney & Super Speciality Ltd changed from 0 % on March 2024 to 0 % on March 2023 . This represents a CAGR of 0.0% over 4 yearsThe Dividend Payout of Invicta Diagnostic Ltd changed from 0 % on March 2024 to 0 % on March 2023 . This represents a CAGR of 0.0% over 4 years .

About Gujarat Kidney & Super Speciality Ltd

Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre.
Subsequently, the Company name was changed to Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.
Further, Company' status was changed to a public limited company and the name of Company was changed to Gujarat Kidney and Super Speciality Limited' dated November 24, 2023 by the ROCs, Ahmedabad. The Company operate a chain of mid-sized multispecialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care.

About Invicta Diagnostic Ltd

Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name 'Invicta Diagnostic LLP' vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre.
Further, Invicta Diagnostic LLP converted into a Private Limited Company as 'Invicta Diagnostic Private Limited' dated December 01, 2023.
Subsequently, Company converted from a Private Limited to a Public Limited Company, and the name was changed to 'Invicta Diagnostic Limited' and a fresh Certificate of Incorporation dated July 02, 2024 was issued by the Central Processing Centre. Invicta Diagnostic Limited is an innovative diagnostic chain in Mumbai Metropolitan Region (MMR) offering comprehensive radiology and pathology solutions.
It offer a one-stop solution for pathology and radiology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers through a network, consisting of 8 diagnostic centres and 1 centralised laboratory across Mumbai Metropolitan Region in Maharashtra.

FAQs for the comparison of Gujarat Kidney & Super Speciality Ltd and Invicta Diagnostic Ltd

Which company has a larger market capitalization, Gujarat Kidney & Super Speciality Ltd or Invicta Diagnostic Ltd?

Market cap of Gujarat Kidney & Super Speciality Ltd is 1,395 Cr while Market cap of Invicta Diagnostic Ltd is 76 Cr

What are the key factors driving the stock performance of Gujarat Kidney & Super Speciality Ltd and Invicta Diagnostic Ltd?

The stock performance of Gujarat Kidney & Super Speciality Ltd and Invicta Diagnostic Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gujarat Kidney & Super Speciality Ltd and Invicta Diagnostic Ltd?

As of October 25, 2026, the Gujarat Kidney & Super Speciality Ltd stock price is INR ₹176.95. On the other hand, Invicta Diagnostic Ltd stock price is INR ₹60.5.

How do dividend payouts of Gujarat Kidney & Super Speciality Ltd and Invicta Diagnostic Ltd compare?

To compare the dividend payouts of Gujarat Kidney & Super Speciality Ltd and Invicta Diagnostic Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.